Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 8, 1999 - Issue 6
Submit an article Journal homepage
13
Views
2
CrossRef citations to date
0
Altmetric
Meeting Report

IBC’s 6th International Symposium on Obesity and 3rd International Symposium on Insulin Resistance: March 22-25, 1999, Washington, DC

James M Lenhard Department of Metabolic Diseases and Department of Medicinal Chemistry 1, Glaxo Wellcome, Inc., 5 Moore Drive, Research Triangle Park, NC 27709, USA
&
Jeff E Cobb Department of Metabolic Diseases and Department of Medicinal Chemistry 1, Glaxo Wellcome, Inc., 5 Moore Drive, Research Triangle Park, NC 27709, USA
Pages 911-916 | Published online: 23 Feb 2005

Bibliography

  • BJORBAEK C, ELMQUIST JK, MICHL P et al.: Expression of leptin receptor isoforms in rat brain microvessels. Endocrinology (1998) 139:3485–3491.
  • BJORBAEK C, ELMQUIST JK, FRANTZ JD, SHOELSON SE, FLIER JS: Identification of SOCS-3 as a potential mediator of central leptin resistance. Mol. Cell (1998) 1:619–625.
  • GARCIA-RUBI E, STARLING RD, TCHERNOF A et al:Trp64Arg variant of the beta3-adrenoceptor and insulin resistance in obese postmenopausal women. J. Endocrinol. Metab. (1998) 83:4002–4005.
  • FISHER MH, AMEND AM, BACH TJ et al: A selectivehuman beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys. J. Clin. Invest. (1998) 101:2387–2393.
  • WEYER C, TATARANNI PA, SNITKER S, DANFORTH E,RAVUSSIN E: Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. Diabetes (1998) 47:1555–1561.
  • PAULIK MA, BUCKHOLZ RG, LANCASTER ME et al:Development of infrared imaging to measure thermo-genesis in cell culture: thermogenic effects of uncoupling protein-2, troglitazone, and beta-adrenoceptor agonists. Pharm. Res. (1998) 15:944–949.
  • COBB JE, BLANCHARD SG, BOSWELL EG et al.:N-(2-Benzoylpheny0-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimi-zation of the N-aryl substituent. J. Med. Chem. (1998) 41:5055–5069.
  • LENHARD JM, LANCASTER ME, PAULIK MA et al: The RXR Agonist LG100268 causes hepatomegaly, improves glycaemic control and decreases cardiovascular risk and cachexia in diabetic mice suffering from pancre-atic beta-cell dysfunction. Diabetologia (1999) 42:(In Press).
  • BERGER J, LEIBOWITZ MD, DOEBBER TW et al.: Novel peroxisome proliferator-activated receptor (PPAID gamma and PPARdelta ligands produce distinct biological effects. J. Biol. Chem. (1999) 274:6718–6725.
  • BURRIS TP, PELTON PD, ZHOU L et al: A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expres-sion detected using branched NA messenger RNA quantitation. Mol. Endocrinol. (1999) 13:410–417.
  • JEZEK P, GARLID KD: Mammalian mitochondrial uncoupling proteins. Int. J. Biochem. Cell Biol. (1998) 30:1163–1168.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.